Deutsche Bank Cuts PT on Harmony Biosciences Holdings (HRMY) to $30 From $31

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) is one of the best cheap biotech stocks to buy now. On February 25, Deutsche Bank adjusted the price target on Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) to $30 from $31 and reiterated a Hold rating on the shares, updating its model on the stock post the fiscal Q4 report. Is Harmony Biosciences Holdings, Inc. (HRMY) the Best Small-Cap Growth Stock to Buy Now? Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) reported strong 2025 financial results on F ...